- Country: Argentina
- Summary: CASPOFUNGIN 70 mg. Model: Caspofungin Acetate 83.9 mg (equivalent to 75.6 mg of anhydrous free acid), injectable, lyophilized, in vial, intravenous use 44.00 Unit
- ART Ref No: 91620468
- Deadline: 06 Nov 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tenders Are Invited CASPOFUNGIN 70 mg. Model: Caspofungin Acetate 83.9 mg (equivalent to 75.6 mg of anhydrous free acid), injectable, lyophilized, in vial, intravenous use 44.00 Unit
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCASPOFUNGIN 70 mg. Model: Caspofungin Acetate 83.9 mg (equivalent to 75.6 mg of anhydrous free acid), injectable, lyophilized, in vial, intravenous use 44.00 Unit - Argentina Tender
The MINISTRY OF HEALTH, a Government sector organization in Argentina, has announced a new tender for CASPOFUNGIN 70 mg. Model: Caspofungin Acetate 83.9 mg (equivalent to 75.6 mg of anhydrous free acid), injectable, lyophilized, in vial, intravenous use 44.00 Unit. This tender is published on ArgentinaTenders under ART Ref No: 91620468 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-11-06.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
